CompanionDx Reference Lab Expands Leadership Team
HOUSTON--(BUSINESS WIRE)--CompanionDx Reference Lab, a high-complexity CLIA certified laboratory specializing in pharmacogenomics, cancer companion diagnostics, targeted NGS and epigenomics testing, today announced the appointment of six new leadership team members to its managed care, marketing and sales organizations. The new positions have been developed in support of its unprecedented growth and continued commitment to servicing existing clients.
“Adding talent of this quality allows us to more quickly reach our goal of being the premier provider of multi-therapeutic solutions specific to DNA sequencing and pharmacogenomics”
“Adding talent of this quality allows us to more quickly reach our goal of being the premier provider of multi-therapeutic solutions specific to DNA sequencing and pharmacogenomics,” said Nikko Khazana, senior vice president of sales for CompanionDx Lab. “Our newly expanded leadership team deepens our bench strength and allows us to focus on strategic priorities and provide exceptional support to our customers.”
The new additions to CompanionDx Lab:
Clint Winter has joined CompanionDx Lab as vice president of payer strategy & managed care. He has more than 20 years of experience in personalized medicine and molecular diagnostics within the biopharmaceutical environment.
Terry Lively brings more than 23 years of healthcare experience to the team as the vice president of new business development – NGS commercialization. His expertise includes pharma/biotech, managed care, sales management, business development, account management and consulting.
Ronald Conheim joins the team as vice president of sales for the eastern U.S. He brings more than 30 years of comprehensive healthcare experience in mental health, oncology, urology and rheumatology.
Roderick Booker, who joins CompanionDx Lab as vice president of sales for the central U.S., possesses more than 20 years of healthcare experience and a proven track record of operational leadership, strategic development and relationship management.
Roger Saadeh will contribute to the team as vice president of sales for the western U.S. and has more than 20 years of healthcare experience in all facets of pharmaceutical supply chain, commercialization services, business development, managed care, and health systems consulting.
Stacey Little, an award winning creative director and expert in brand and marketing strategy, will lead strategic marketing, marketing communications and brand management for the U.S. and international markets as the vice president of marketing & communications.
About CompanionDxTM Lab
With locations in Houston, Texas and Honolulu, Hawaii, CompanionDx Reference Lab is a high-complexity CLIA certified laboratory specializing in pharmacogenomics, cancer companion diagnostics, targeted NGS and epigenomics testing. CompanionDx Lab is committed to the next evolution in cancer care where comprehensive genetic data is delivered in an actionable format, thereby enabling the physician to make treatment decisions and choose healthcare strategies based on unique cancer type and the genetic makeup of each patient. CompanionDx Lab’s comprehensive and tumor-specific panels, coupled with personalized pharmacogenomic analysis, provide a unique offering that allows physicians to choose relevant and targeted therapies.
For more information, visit www.companiondxlab.com.